Transparent and complete reporting of surrogate endpoints in trials: the SPIRIT-Surrogate and CONSORT-Surrogate extensions

Lancet. 2024 Jul 27;404(10450):322-324. doi: 10.1016/S0140-6736(24)01306-0. Epub 2024 Jul 11.
No abstract available

MeSH terms

  • Biomarkers*
  • Clinical Trials as Topic
  • Endpoint Determination
  • Humans
  • Randomized Controlled Trials as Topic / standards
  • Research Design / standards

Substances

  • Biomarkers